Related Experiment Video
Updated: Jun 11, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc
Paul J Keall1, Amit Sawant, Byungchul Cho
1Department of Radiation Oncology, Stanford University, Stanford, CA 94305-5847, USA. keall@stanford.edu
Summary
Electromagnetic-guided dynamic multileaf collimator (DMLC) tracking significantly improved dose distributions for intensity-modulated arc therapy (IMAT) in moving targets. This novel DMLC tracking technology enhances cancer treatment without compromising efficiency.
Area of Science:
- Radiation Oncology
- Medical Physics
- Image-Guided Therapy
Background:
- Intensity-modulated arc therapy (IMAT) offers high-dose conformity and efficient delivery.
- Managing intrafraction motion remains a significant challenge for IMAT efficacy.
- Current clinical practices struggle to accurately treat moving targets during IMAT.
Purpose of the Study:
- To develop and evaluate an electromagnetically guided dynamic multileaf collimator (DMLC) tracking system.
- To investigate DMLC tracking as a method for treating moving targets during IMAT.
- To assess the dosimetric accuracy and efficiency of DMLC-IMAT for mobile tumors.
Main Methods:
- A real-time 3D DMLC tracking system was integrated with a linear accelerator.
- The system dynamically adjusted leaf positions based on electromagnetic target position data and IMAT plans.
- Dosimetric measurements were performed on a motion platform simulating patient movement, comparing DMLC tracking, no tracking, and static conditions using a gamma-test.
Main Results:
- With DMLC tracking, only 1.6% (lung) and 1.2% (prostate) of dose points failed the 3-mm/3% gamma-test.
- Without tracking, failure rates increased significantly to 34% (lung) and 14% (prostate).
- Treatment delivery time remained consistent with or without DMLC tracking.
Conclusions:
- Electromagnetic-guided DMLC target tracking represents a novel approach for IMAT.
- DMLC tracking demonstrated significantly superior dose distributions for moving targets compared to non-tracking methods.
- This technology enhances treatment accuracy for moving targets in IMAT without sacrificing treatment efficiency.

